Synlogic Inc (NASDAQ:SYBX)
| 2.09 Delayed Data As of Jan 14 |  +0.06 / +3.02%Today’s Change | 1.92 Today|||52-Week Range 5.11 | -13.64% Year-to-Date |
Latest SYBX News | Press Releases
No recent news for Synlogic Inc.
Today’s Trading
| Previous close | 1.99 |
| Today’s open | 2.02 |
| Day’s range | 1.92 - 2.08 |
| Volume | 95,871 |
| Average volume (3 months) | 414,465 |
| Market cap | $139.4M |
Data as of 3:59pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | +2.66% |
| Earnings growth (this year) | +29.45% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -75.49% |
| P/E ratio | NM |
| Price/Sales | 142.03 |
| Price/Book | 0.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SEELSeelos Therapeutics ... | +0.01 | +0.71% |
| PRTGPortage Biotech Inc | +0.11 | +1.05% |
| NCNANuCana PLC | +0.15 | +5.54% |
| LJPCLa Jolla Pharmaceuti... | +0.17 | +3.58% |
Data as of 4:00pm ET, 01/14/2022
Financials
| Next reporting date | March 23, 2022 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $545.0K |
| Annual profit (last year) | -$59.2M |
| Net profit margin | -10,857.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
